If a Product Has No Marketing Authorisation, What Checks Matter Most?

In the UK healthcare system, medicines with no marketing authorisation — often called unlicensed or "specials" — pose distinct challenges. Unlike licensed products, they lack the regulatory assurances of standard quality, safety, and efficacy. That raises an important question for pharmacy professionals: What checks matter most when handling unlicensed products?

This blog post explores the critical controls in place for unlicensed products, with a focus on how electronic prescribing, dispensing workflow integration, and automation technologies support quality assurance and traceability in their use.

Understanding the Regulatory Context

Before unpacking operational controls, a reminder of the regulatory framework is key. The Medicines and Healthcare products Regulatory Agency (MHRA) requires that unlicensed medicines only be supplied when there is no suitable licensed alternative and a clinician takes responsibility for their use.

Marketing Authorisation (MA): A formal approval by MHRA or EMA ensuring a product meets rigorous standards.
Unlicensed Products: Medicines without such an authorisation, either specials or imported medicines.

Pharmacies therefore must apply additional quality assurance, traceability, and patient safety checks beyond those for licensed medicines. This ensures compliance with GPhC standards and mitigates risks related to unknown product profiles.

Electronic Transmission of Prescriptions: Safeguarding Demand and Nominations

The move from paper prescriptions to electronic prescription service (EPS) is central to modern medicines optimisation. EPS enables faster, more accurate prescribing and supports critical controls for unlicensed products:

Verification of Prescriber Intent: Electronic records clearly specify if a medicine is unlicensed, making it impossible to accidentally substitute licensed alternatives without approval.
Nominations and Patient Choice: EPS supports patient nomination to preferred pharmacies, ensuring unlicensed medicines reach pharmacies with proper capabilities.
Demand Forecasting: Aggregated e-prescription data over time improves forecasting for specials, helping pharmacies maintain compliant stock levels rather than reactive ordering.

From an analyst perspective, the most important question always is: What regulatory requirement is this step satisfying?

EPS meets MHRA’s traceability and accountability expectations by recording prescriber details and exact product specifications.
It supports GPhC’s emphasis on appropriate supply routes for specials.

Dispensing Workflow Integration: Checking the Unlicensed Product at Every Point

Dispensing workflow systems, integrated with EPS and pharmacy management software, play a vital role in controlling unlicensed products. Key features include:

Flagging Unlicensed Medicines: The system alerts dispensers that the medicine has no marketing authorisation and requires specific handling.
Verification Prompts: Automated checks ensure the product dispensed matches the prescription exactly, reducing errors.
Additional Documentation Fields: Capture special patient consent, prescriber responsibility, and supplier details.

These workflow controls satisfy several regulatory requirements:

Quality Assurance: Validating supplier credentials and batch information before dispensing.
Traceability: Documenting product batch numbers and expiry, critical if an adverse event occurs.
Patient Safety: Confirming the patient understands the medicine‘s unlicensed status and any special storage or administration instructions.

Concrete Example: A Dispensing Workflow in Practice

Consider a patient prescribed a special formulation for a rare condition.

The electronic prescription flags the product as unlicensed.
The pharmacy system prompts the dispenser to verify the supplier's specials licence and batch number before supply.
The dispenser scans the product barcode, linking batch data with patient records for full traceability.
Consent forms are electronically attached to the record, meeting GPhC standards.

This combination guarantees steps that look like logistics are actually satisfying licensing requirements.

Repeat Dispensing Scheduling: Managing Ongoing Supplies Safely

Repeat dispensing of unlicensed medicines adds complexity. Unlike licensed products, there may be limited uk pharmacy supply chain shelf-life or manufacturing changes requiring closer monitoring.

Pharmacy systems integrated with EPS enable:

Scheduled Review Prompts: For every repeat, a prompt ensures reassessment of prescribing appropriateness and stock validation.
Expiry Date Checks: Alerts prevent supply of expired specials.
Dynamic Quantity Management: Adjust quantities to reflect patient response or product availability, helping meet MHRA expectations for good distribution practice.

Effective control of repeat unlicensed dispensing requires coordination between prescriber, pharmacy, and patient — something workflow software and EPS make far more achievable.

Robotic Dispensing and Barcode Traceability: Automation Boosting Compliance

Robotic dispensing systems have transformed throughput in high-volume pharmacies. When configured correctly, they add key controls for unlicensed products:

Barcode Scanning for Batch Traceability: Each product scan validates both product and batch against prescription record, creating an electronic audit trail.
Exception Handling Workflows: Robots flag discrepancies for human review, preventing inadvertent supply of incorrect specials.
Integration with Inventory Data: Ensures stock records correspond to traceable batches, satisfying MHRA’s track-and-trace requirements.

Automating checks reduces human error but each additional scan also impacts throughput cost. It’s important to balance regulatory compliance https://technivorz.com/do-specials-need-mhra-assessment-or-marketing-authorisation/ with efficiency – a trade-off often ignored in hype about "digital transformation."

Things That Look Like Logistics But Are Actually Licensing

In this context, several steps may appear purely logistical but satisfy licensing or regulatory needs:

Scanning products multiple times isn’t just for stock accuracy — it ensures batch traceability critical for patient safety.
Recording supplier license details embeds quality assurance into dispensing.
Logging patient consent electronically meets MHRA and GPhC documentation requirements.

Understanding these distinctions avoids a cookie-cutter "retail" approach to dispensing unlicensed medicines.

Summary of Critical Checks for Unlicensed Products

Check Type Purpose Tools/Processes Regulatory Requirement Product Verification Confirm product matches prescription & supplier is licensed Dispensing workflow alerts, barcode scanning MHRA batch traceability, GPhC standards Documentation and Consent Ensure patient informed, liability assigned Electronic records, consent capture GPhC responsibility, MHRA accountability Order and Stock Management Maintain appropriate stock levels, expiry checks EPS nomination, forecasting tools Good Distribution Practice (GDP) Repeat Dispensing Control Review ongoing use, adjust quantities Scheduled system prompts Patient safety reassessment Traceability and Audit Trail Record batch/lot for recall or ADR Barcode traceability, automatic logs MHRA recall capability

Final Thoughts: Quality Assurance Is a Multifaceted Process

Handling unlicensed products demands more than the standard pharmacy checklist. The integration of electronic prescription transmission, dispensing workflow systems, and robotic automation combine to create a rigorous environment of checks that satisfy essential MHRA and GPhC requirements.

Always ask: What regulatory requirement is this step satisfying? This approach helps cut through empty buzzwords about digital transformation, revealing the concrete compliance needs behind every scan, prompt, and confirmation.

By embracing these checks, pharmacies protect patients, maintain trust in specials supplies, and meet their legal responsibilities — all critical in a landscape where no marketing authorisation requires zero margin for error.